近視治療市場規模・予測（2020年～2030年）、世界・地域シェア、動向、成長機会分析レポート対象範囲：タイプ別（強度近視、変性近視、進行性近視）、治療法別（低用量アトロピン点眼薬、コンタクトレンズ、オルソK、屈折矯正手術（レーシック、PRK））、年齢層別（成人近視、小児近視）、エンドユーザー別（病院・クリニック、専門クリニック、屈折矯正手術センター）、地域別

Myopia Treatment Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (High Myopia, Degenerative Myopia, Progressive Myopia), Treatment [Low-Dose Atropine Eye Drops, Contact Lenses, Ortho-K, and Refractive Surgery (LASIK, PRK)], Age Group (Adult Myopia and Childhood Myopia), End User (Hospitals and Clinics, Specialty Clinics, and Refractive Surgery Centers), and Geography

世界の近視治療市場は、2022年の102億7,600万米ドルから2030年には195億7,100万米ドルに達すると予測されている。2022年から2030年までの年平均成長率は8.39%と推定される。市場成長を促進する主な要因は、近... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2024年1月10日	US$5,190 シングルユーザライセンスライセンス・価格情報注文方法はこちら	206	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

世界の近視治療市場は、2022年の102億7,600万米ドルから2030年には195億7,100万米ドルに達すると予測されている。2022年から2030年までの年平均成長率は8.39%と推定される。

市場成長を促進する主な要因は、近視有病率の上昇と近視治療に対する意識の高まりである。しかし、熟練した専門家の不足が近視治療市場の成長を妨げている。

近視治療市場の市場機会

対象となる近視を治療するための先端技術の利用可能性が高まっていることも、近視治療市場にとって重要な機会である。レーザー支援下インサイチュ角膜切除術（LASIK）、光屈折矯正術（PRK）、植込み型コラーレンズ（ICL）などの技術の進歩により、より効果的に、より少ない合併症で近視を矯正することが可能になった。例えば、ジョンソン・エンド・ジョンソン・ビジョンは2023年8月、第41回欧州白内障屈折矯正手術学会（ESCRS）において、次世代レーザー視力矯正ソリューション「ELITATMプラットフォーム」を発表した。また、大会期間中には様々な画期的なデータが発表され、ジョンソン・エンド・ジョンソンビジョンの支援を受けた30以上の演題が発表に承認された。外科医は革新的なSILK(Smooth Incision Lenticule Keratomileusis)治療を乱視のある近視患者の治療に適用することができ、ELITATMプラットフォームを利用することもできます。ELITATMプラットフォームは、その高速レーザー照射技術と超精密レーザーパルスにより、翌日には結果が得られ回復する、非常にスムーズで簡便なレンズ嚢切除術を外科医に提供します。このような高度な技術は、従来は高価で、多くの患者には手が届かなかった。しかし、これらの技術がより広く利用されるようになれば、近視治療市場がその範囲を拡大し、より多くの患者集団により良い治療オプションを提供するチャンスとなる。これらの先端技術に加え、オルソケラトロジー（オルソk）やアトロピン点眼薬などの新たな治療法も、近視を管理する効果的な方法として人気を集めている。2021年5月、クーパービジョン・スペシャルティ・アイケアのプロコルネア・ドリームライト・ナイトレンズは、小児および若年成人の近視進行を遅らせるという効能で欧州の承認を取得した。この人気のオルソケラトロジーコンタクトレンズは、EyeDreamとParagon CRTオルソKデザイン、MiSightデイソフトコンタクトレンズ、SightGlass Vision Diffusion Optics Technologyメガネレンズに続き、CEマークを取得した最新のクーパービジョン近視コントロール製品である。これらの非侵襲的な治療は、外科的な選択肢よりも手頃な価格で、より幅広い患者にとって利用しやすいものとなっている。全体として、対象となる近視を治療するための高度な技術が利用可能になりつつあることは、近視治療市場に大きな機会をもたらしている。患者により効果的で利用しやすい治療法を提供することで、この市場は視力の健康状態を改善し、世界のヘルスケア状況における重要なアンメットニーズに対応することができる。

近視治療市場を阻害する要因

近視治療市場は、近視管理を専門とする熟練した眼科医療従事者の不足という重大な課題に直面している。近視の流行が世界的に数百万人に影響を及ぼしているため、近視のコントロールと管理の訓練を受けた熟練した検眼士や眼科医の需要が急増しています。しかし、オルソケラトロジーやアトロピン療法などの近視治療計画を効果的に実施・監視できる専門家の不足が、これらの進歩的治療法の普及を妨げている。この不足は、特に若年層における近視の有病率の増加によって悪化しており、近視管理に対する積極的かつ包括的なアプローチが必要となっている。この不足に対処するための努力は、近視に焦点を当てた治療を提供するために必要なスキルを眼科医療従事者に身につけさせるための教育訓練プログラムを拡充することである。これにより、市場は近視治療に対する需要の高まりに効果的に対応し、視覚衛生の向上に貢献することができます。

近視治療市場：セグメント別概要

近視治療市場は、タイプ別に、強度近視、変性近視、進行性近視に区分される。2022年の近視治療市場では、強度近視分野が最大のシェアを占めている。高度近視は、病的近視または変性近視としても知られ、著しく伸長した眼球と眼合併症のリスク増大を特徴とする高度な近視を表す。強度近視の患者は、しばしば重度の視力障害を経験し、網膜剥離、近視性黄斑症、緑内障、脈絡膜新生血管など、視力を脅かすさまざまな疾患にかかりやすい。この症状は通常、小児期から青年期にかけて進行し、読書や車の運転が困難になるなど、個人の生活の質に大きな影響を与えます。

近視治療市場は、治療法に基づき、低用量アトロピン点眼薬、屈折矯正手術、コンタクトレンズ、オルソKに区分される。2022年の近視治療市場では、低用量アトロピン点眼薬セグメントが最大のシェアを占めている。低用量アトロピン点眼薬は、特に小児や青少年における近視の有望な治療薬である。近視は、しばしば近視として知られ、遠くのものがぼんやりと見える屈折異常である。アトロピンは、目のピント調節筋を低下させ、瞳孔を拡張させることで、近視の進行を遅らせることができる薬です。

近視治療市場は、年齢層別に成人近視と小児近視に区分される。2022年の近視治療市場では、成人近視分野が最大のシェアを占めている。成人近視は、遠くのものが見えにくいという特徴があり、クリアな視界を得るために矯正レンズが必要になることが多い。成人期における近視の発症と進行は、読書やコンピューター作業から運転や屋外活動への参加まで、日常生活の様々な特徴に影響を与える可能性がある。矯正に頼る不便さだけでなく、成人近視は、近視性黄斑症、白内障、緑内障の発症リスクの増加など、長期的な眼の健康上の懸念につながる可能性があります。

エンドユーザー別に見ると、近視治療市場は病院・クリニック、専門クリニック、屈折矯正手術センターに分類される。病院・診療所セグメントは、2022年の近視治療市場で最大のシェアを占めた。病院と診療所は、様々な病気や健康状態の治療を提供する主要な医療施設である。病院は最高の設備と患者サービスで一次医療を提供する。病院の眼科医は何千人もの様々な眼疾患を持つ患者を治療している。病院では最高の医師と補助スタッフがいるため、治療が簡単に行える。

近視治療市場：地理的概観

近視治療市場は、地域別に北米、欧州、アジア太平洋、中南米、中東・アフリカに区分される。2022年には、北米が世界の近視治療市場で最大のシェアを占めた。アジア太平洋地域は、2022年から2030年にかけて最も高いCAGRを記録すると推定されている。

米国の近視治療市場は、今後数年間で大きな成長が見込まれる。近視の有病率は近年増加傾向にあり、これが効果的な治療に対する需要を促進している。2023年にMyopia Instituteが発表したデータによると、米国では42%の有病率が報告されており、わずか30年でほぼ倍増している。さらに、近視に対する意識の高まりも市場成長の原動力となっている。例えば、ブリエン・ホールデン・ビジョン・インスティテュートが主催する2024年近視啓発週間は、Review of Myopia Managementを公式共同スポンサーに選んだ。この協力は、2024年5月13日から19日にかけて国内外で開催される近視啓発週間のリーチ拡大を支援する。近視は、白内障や緑内障といった他の眼疾患の発症リスクを高めるなど、近視に伴うリスクを認識する人が増えています。このため、近視を予防したり進行を遅らせたりする効果的な治療法に対する需要が高まっている。米国における近視治療市場の成長を促進するもう一つの要因は、高度な技術と治療法が利用可能になったことである。矯正レンズ、オルソケラトロジー、薬理学的治療など、近視のさまざまな治療法が利用できるようになっている。これらの治療法はますます洗練され、効果的になってきており、近視治療の需要を後押ししている。最後に、小児の近視有病率の増加も、米国における近視治療市場の成長を後押ししている。近視と診断される子供が増えるにつれ、近視の予防や進行を遅らせる効果的な治療法の必要性が高まっている。このため、小児用に特別に設計された新しい治療法の研究開発への投資が増加している。全体として、米国の近視治療市場は、より多くの人々が近視を認識し、効果的な治療に対する需要が高まるにつれて、今後数年間で成長すると予想される。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Myopia Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Market Share Analysis, By Companies
5. Myopia Treatment Market – Key Market Dynamics
5.1 Myopia Treatment Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Myopia
5.2.2 Increased Awareness of Myopia Treatment
5.3 Market Restraints
5.3.1 Lack of Skilled Professionals
5.4 Market Opportunities
5.4.1 Rising Availability of Advanced Technologies For Treating The Targeted Myopia
5.5 Future Trends
5.5.1 Application of Artificial Intelligence In Myopia Treatment
5.6 Impact of Drivers and Restraints:
6. Myopia Treatment Market – Global Market Analysis
7. Myopia Treatment Market Analysis – by Type
7.1 High Myopia
7.1.1 Overview
7.1.2 High Myopia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Degenerative Myopia
7.2.1 Overview
7.2.2 Degenerative Myopia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Progressive Myopia
7.3.1 Overview
7.3.2 Progressive Myopia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8. Myopia Treatment Market Analysis – by Treatment
8.1 Low-Dose Atropine Eye Drops
8.1.1 Overview
8.1.2 Low-Dose Atropine Eye Drops: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Refractive Surgery
8.2.1 Overview
8.2.2 Refractive Surgery: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2.3 LASIK
8.2.4 PRK
8.3 Contact Lenses
8.3.1 Overview
8.3.2 Contact Lenses: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Ortho-K
8.4.1 Overview
8.4.2 Ortho-K: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. Myopia Treatment Market Analysis – by Age Group
9.1 Adult Myopia
9.1.1 Overview
9.1.2 Adult Myopia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Childhood Myopia
9.2.1 Overview
9.2.2 Childhood Myopia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10. Myopia Treatment Market Analysis – by End User
10.1 Hospitals and Clinics
10.1.1 Overview
10.1.2 Hospitals and Clinics: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Specialty Clinics
10.2.1 Overview
10.2.2 Specialty Clinics: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Refractive Surgery Centers
10.3.1 Overview
10.3.2 Refractive Surgery Centers: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11. Myopia Treatment Market – Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Myopia Treatment Market Overview
11.2.2 North America: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.2.2.1 North America: Myopia Treatment Market – Revenue and Forecast Analysis – by Type
11.2.2.2 North America: Myopia Treatment Market – Revenue and Forecast Analysis – by Treatment
11.2.2.3 North America: Myopia Treatment Market – Revenue and Forecast Analysis – by Refractive Surgery
11.2.2.4 North America: Myopia Treatment Market – Revenue and Forecast Analysis – by Age Group
11.2.2.5 North America: Myopia Treatment Market – Revenue and Forecast Analysis – by End User
11.2.3 North America: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.2.3.1 North America: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.2.3.2 US
11.2.3.3 US: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.3.1 US: Myopia Treatment Market Breakdown, by Type
11.2.3.3.2 US: Myopia Treatment Market Breakdown, by Treatment
11.2.3.3.3 US: Myopia Treatment Market Breakdown, by Refractive Surgery
11.2.3.3.4 US: Myopia Treatment Market Breakdown, by Age Group
11.2.3.3.5 US: Myopia Treatment Market Breakdown, by End User
11.2.3.4 Canada
11.2.3.5 Canada: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.5.1 Canada: Myopia Treatment Market Breakdown, by Type
11.2.3.5.2 Canada: Myopia Treatment Market Breakdown, by Treatment
11.2.3.5.3 Canada: Myopia Treatment Market Breakdown, by Refractive Surgery
11.2.3.5.4 Canada: Myopia Treatment Market Breakdown, by Age Group
11.2.3.5.5 Canada: Myopia Treatment Market Breakdown, by End User
11.2.3.6 Mexico
11.2.3.7 Mexico: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.7.1 Mexico: Myopia Treatment Market Breakdown, by Type
11.2.3.7.2 Mexico: Myopia Treatment Market Breakdown, by Treatment
11.2.3.7.3 Mexico: Myopia Treatment Market Breakdown, by Refractive Surgery
11.2.3.7.4 Mexico: Myopia Treatment Market Breakdown, by Age Group
11.2.3.7.5 Mexico: Myopia Treatment Market Breakdown, by End User
11.3 Europe
11.3.1 Overview
11.3.2 Europe: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.3.2.1 Europe: Myopia Treatment Market – Revenue and Forecast Analysis – by Type
11.3.2.2 Europe: Myopia Treatment Market – Revenue and Forecast Analysis – by Treatment
11.3.2.3 Europe: Myopia Treatment Market – Revenue and Forecast Analysis – by Refractive Surgery
11.3.2.4 Europe: Myopia Treatment Market – Revenue and Forecast Analysis – by Age Group
11.3.2.5 Europe: Myopia Treatment Market – Revenue and Forecast Analysis – by End User
11.3.3 Europe: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.3.3.1 Europe: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.3.3.2 Germany
11.3.3.3 Germany: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.3.1 Germany: Myopia Treatment Market Breakdown, by Type
11.3.3.3.2 Germany: Myopia Treatment Market Breakdown, by Treatment
11.3.3.3.3 Germany: Myopia Treatment Market Breakdown, by Refractive Surgery
11.3.3.3.4 Germany: Myopia Treatment Market Breakdown, by Age Group
11.3.3.3.5 Germany: Myopia Treatment Market Breakdown, by End User
11.3.3.4 France
11.3.3.5 France: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.5.1 France: Myopia Treatment Market Breakdown, by Type
11.3.3.5.2 France: Myopia Treatment Market Breakdown, by Treatment
11.3.3.5.3 France: Myopia Treatment Market Breakdown, by Refractive Surgery
11.3.3.5.4 France: Myopia Treatment Market Breakdown, by Age Group
11.3.3.5.5 France: Myopia Treatment Market Breakdown, by End User
11.3.3.6 UK
11.3.3.7 UK: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.7.1 UK: Myopia Treatment Market Breakdown, by Type
11.3.3.7.2 UK: Myopia Treatment Market Breakdown, by Treatment
11.3.3.7.3 UK: Myopia Treatment Market Breakdown, by Refractive Surgery
11.3.3.7.4 UK: Myopia Treatment Market Breakdown, by Age Group
11.3.3.7.5 UK: Myopia Treatment Market Breakdown, by End User
11.3.3.8 Italy
11.3.3.9 Italy: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.9.1 Italy: Myopia Treatment Market Breakdown, by Type
11.3.3.9.2 Italy: Myopia Treatment Market Breakdown, by Treatment
11.3.3.9.3 Italy: Myopia Treatment Market Breakdown, by Refractive Surgery
11.3.3.9.4 Italy: Myopia Treatment Market Breakdown, by Age Group
11.3.3.9.5 Italy: Myopia Treatment Market Breakdown, by End User
11.3.3.10 Spain
11.3.3.11 Spain: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.11.1 Spain: Myopia Treatment Market Breakdown, by Type
11.3.3.11.2 Spain: Myopia Treatment Market Breakdown, by Treatment
11.3.3.11.3 Spain: Myopia Treatment Market Breakdown, by Refractive Surgery
11.3.3.11.4 Spain: Myopia Treatment Market Breakdown, by Age Group
11.3.3.11.5 Spain: Myopia Treatment Market Breakdown, by End User
11.3.3.12 Rest of Europe
11.3.3.13 Rest of Europe: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.13.1 Rest of Europe: Myopia Treatment Market Breakdown, by Type
11.3.3.13.2 Rest of Europe: Myopia Treatment Market Breakdown, by Treatment
11.3.3.13.3 Rest of Europe: Myopia Treatment Market Breakdown, by Refractive Surgery
11.3.3.13.4 Rest of Europe: Myopia Treatment Market Breakdown, by Age Group
11.3.3.13.5 Rest of Europe: Myopia Treatment Market Breakdown, by End User
11.4 Asia Pacific
11.4.1 Overview
11.4.2 Asia Pacific: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.4.2.1 Asia Pacific: Myopia Treatment Market – Revenue and Forecast Analysis – by Type
11.4.2.2 Asia Pacific: Myopia Treatment Market – Revenue and Forecast Analysis – by Treatment
11.4.2.3 Asia Pacific: Myopia Treatment Market – Revenue and Forecast Analysis – by Refractive Surgery
11.4.2.4 Asia Pacific: Myopia Treatment Market – Revenue and Forecast Analysis – by Age Group
11.4.2.5 Asia Pacific: Myopia Treatment Market – Revenue and Forecast Analysis – by End User
11.4.3 Asia Pacific: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.4.3.1 Asia Pacific: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.4.3.2 China
11.4.3.3 China: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.3.1 China: Myopia Treatment Market Breakdown, by Type
11.4.3.3.2 China: Myopia Treatment Market Breakdown, by Treatment
11.4.3.3.3 China: Myopia Treatment Market Breakdown, by Refractive Surgery
11.4.3.3.4 China: Myopia Treatment Market Breakdown, by Age Group
11.4.3.3.5 China: Myopia Treatment Market Breakdown, by End User
11.4.3.4 Japan
11.4.3.5 Japan: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.5.1 Japan: Myopia Treatment Market Breakdown, by Type
11.4.3.5.2 Japan: Myopia Treatment Market Breakdown, by Treatment
11.4.3.5.3 Japan: Myopia Treatment Market Breakdown, by Refractive Surgery
11.4.3.5.4 Japan: Myopia Treatment Market Breakdown, by Age Group
11.4.3.5.5 Japan: Myopia Treatment Market Breakdown, by End User
11.4.3.6 India
11.4.3.7 India: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.7.1 India: Myopia Treatment Market Breakdown, by Type
11.4.3.7.2 India: Myopia Treatment Market Breakdown, by Treatment
11.4.3.7.3 India: Myopia Treatment Market Breakdown, by Refractive Surgery
11.4.3.7.4 India: Myopia Treatment Market Breakdown, by Age Group
11.4.3.7.5 India: Myopia Treatment Market Breakdown, by End User
11.4.3.8 Australia
11.4.3.9 Australia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.9.1 Australia: Myopia Treatment Market Breakdown, by Type
11.4.3.9.2 Australia: Myopia Treatment Market Breakdown, by Treatment
11.4.3.9.3 Australia: Myopia Treatment Market Breakdown, by Refractive Surgery
11.4.3.9.4 Australia: Myopia Treatment Market Breakdown, by Age Group
11.4.3.9.5 Australia: Myopia Treatment Market Breakdown, by End User
11.4.3.10 South Korea
11.4.3.11 South Korea: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.11.1 South Korea: Myopia Treatment Market Breakdown, by Type
11.4.3.11.2 South Korea: Myopia Treatment Market Breakdown, by Treatment
11.4.3.11.3 South Korea: Myopia Treatment Market Breakdown, by Refractive Surgery
11.4.3.11.4 South Korea: Myopia Treatment Market Breakdown, by Age Group
11.4.3.11.5 South Korea: Myopia Treatment Market Breakdown, by End User
11.4.3.12 Rest of APAC
11.4.3.13 Rest of APAC: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.13.1 Rest of APAC: Myopia Treatment Market Breakdown, by Type
11.4.3.13.2 Rest of APAC: Myopia Treatment Market Breakdown, by Treatment
11.4.3.13.3 Rest of APAC: Myopia Treatment Market Breakdown, by Refractive Surgery
11.4.3.13.4 Rest of APAC: Myopia Treatment Market Breakdown, by Age Group
11.4.3.13.5 Rest of APAC: Myopia Treatment Market Breakdown, by End User
11.5 Middle East and Africa
11.5.1 Overview
11.5.2 Middle East and Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3 Middle East and Africa: Myopia Treatment Market Breakdown, by Type
11.5.3.1 Middle East and Africa: Myopia Treatment Market – Revenue and Forecast Analysis – by Type
11.5.3.2 Middle East and Africa: Myopia Treatment Market – Revenue and Forecast Analysis – by Treatment
11.5.3.3 Middle East and Africa: Myopia Treatment Market – Revenue and Forecast Analysis – by Refractive Surgery
11.5.3.4 Middle East and Africa: Myopia Treatment Market – Revenue and Forecast Analysis – by Age Group
11.5.3.5 Middle East and Africa: Myopia Treatment Market – Revenue and Forecast Analysis – by End User
11.5.4 Middle East and Africa: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.5.4.1 Middle East and Africa: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.5.4.2 Saudi Arabia
11.5.4.3 Saudi Arabia: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.5.4.3.1 Saudi Arabia: Myopia Treatment Market Breakdown, by Type
11.5.4.3.2 Saudi Arabia: Myopia Treatment Market Breakdown, by Treatment
11.5.4.3.3 Saudi Arabia: Myopia Treatment Market Breakdown, by Refractive Surgery
11.5.4.3.4 Saudi Arabia: Myopia Treatment Market Breakdown, by Age Group
11.5.4.3.5 Saudi Arabia: Myopia Treatment Market Breakdown, by End User
11.5.4.4 South Africa
11.5.4.5 South Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.5.4.5.1 South Africa: Myopia Treatment Market Breakdown, by Type
11.5.4.5.2 South Africa: Myopia Treatment Market Breakdown, by Treatment
11.5.4.5.3 South Africa: Myopia Treatment Market Breakdown, by Refractive Surgery
11.5.4.5.4 South Africa: Myopia Treatment Market Breakdown, by Age Group
11.5.4.5.5 South Africa: Myopia Treatment Market Breakdown, by End User
11.5.4.6 UAE
11.5.4.7 UAE: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.5.4.7.1 UAE: Myopia Treatment Market Breakdown, by Type
11.5.4.7.2 UAE: Myopia Treatment Market Breakdown, by Treatment
11.5.4.7.3 UAE: Myopia Treatment Market Breakdown, by Refractive Surgery
11.5.4.7.4 UAE: Myopia Treatment Market Breakdown, by Age Group
11.5.4.7.5 UAE: Myopia Treatment Market Breakdown, by End User
11.5.4.8 Rest of Middle East and Africa
11.5.4.9 Rest of Middle East and Africa: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.5.4.9.1 Rest of Middle East and Africa: Myopia Treatment Market Breakdown, by Type
11.5.4.9.2 Rest of Middle East and Africa: Myopia Treatment Market Breakdown, by Treatment
11.5.4.9.3 Rest of Middle East and Africa: Myopia Treatment Market Breakdown, by Refractive Surgery
11.5.4.9.4 Rest of Middle East and Africa: Myopia Treatment Market Breakdown, by Age Group
11.5.4.9.5 Rest of Middle East and Africa: Myopia Treatment Market Breakdown, by End User
11.6 South and Central America
11.6.1 Overview
11.6.2 South and Central America: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.6.2.1 South and Central America: Myopia Treatment Market – Revenue and Forecast Analysis – by Type
11.6.2.2 South and Central America: Myopia Treatment Market – Revenue and Forecast Analysis – by Treatment
11.6.2.3 South and Central America: Myopia Treatment Market – Revenue and Forecast Analysis – by Refractive Surgery
11.6.2.4 South and Central America: Myopia Treatment Market – Revenue and Forecast Analysis – by Age Group
11.6.2.5 South and Central America: Myopia Treatment Market – Revenue and Forecast Analysis – by End User
11.6.3 South and Central America: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.6.3.1 South and Central America: Myopia Treatment Market – Revenue and Forecast Analysis – by Country
11.6.3.2 Brazil
11.6.3.3 Brazil: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.3.1 Brazil: Myopia Treatment Market Breakdown, by Type
11.6.3.3.2 Brazil: Myopia Treatment Market Breakdown, by Treatment
11.6.3.3.3 Brazil: Myopia Treatment Market Breakdown, by Refractive Surgery
11.6.3.3.4 Brazil: Myopia Treatment Market Breakdown, by Age Group
11.6.3.3.5 Brazil: Myopia Treatment Market Breakdown, by End User
11.6.3.4 Argentina
11.6.3.5 Argentina: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.5.1 Argentina: Myopia Treatment Market Breakdown, by Type
11.6.3.5.2 Argentina: Myopia Treatment Market Breakdown, by Treatment
11.6.3.5.3 Argentina: Myopia Treatment Market Breakdown, by Refractive Surgery
11.6.3.5.4 Argentina: Myopia Treatment Market Breakdown, by Age Group
11.6.3.5.5 Argentina: Myopia Treatment Market Breakdown, by End User
11.6.3.6 Rest of South and Central America
11.6.3.7 Rest of South and Central America: Myopia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.7.1 Rest of South and Central America: Myopia Treatment Market Breakdown, by Type
11.6.3.7.2 Rest of South and Central America: Myopia Treatment Market Breakdown, by Treatment
11.6.3.7.3 Rest of South and Central America: Myopia Treatment Market Breakdown, by Refractive Surgery
11.6.3.7.4 Rest of South and Central America: Myopia Treatment Market Breakdown, by Age Group
11.6.3.7.5 Rest of South and Central America: Myopia Treatment Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Myopia Treatment Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Bausch Health Companies Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Alcon AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CooperVision Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson Vision Care Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Topcon Healthcare Solutions Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Ziemer Ophthalmic Systems AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Nidek Co Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Eyes Vision SL
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Haag-Streit AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Carl Zeiss AG
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

The global myopia treatment market is expected to reach US$ 19.571 billion in 2030 from US$ 10.276 billion in 2022. The market is estimated to grow with a CAGR of 8.39% from 2022 to 2030.

Key factors driving the market growth are the rising prevalence of myopia and increased awareness of myopia treatment. However, the lack of skilled professionals hinders the myopia treatment market growth.

Market Opportunities of Myopia Treatment Market

The rising availability of advanced technologies for treating targeted myopia is another significant opportunity for the myopia treatment market. Advances in technologies such as laser-assisted in-situ keratomileusis (LASIK), photorefractive keratectomy (PRK), and implantable collamer lenses (ICL) have made it possible to correct myopia more effectively and with fewer complications. For instance, In August 2023, Johnson & Johnson Vision launched a next-generation laser vision correction solution, the ELITATM Platform, during the 41st European Society of Cataract and Refractive Surgeons (ESCRS) congress. Various ground-breaking data was also presented during the congress; over thirty abstracts backed by Johnson & Johnson Vision have been approved for presentation. Surgeons can apply the innovative SILK (Smooth Incision Lenticule Keratomileusis) treatment to treat myopic patients who have astigmatism or do not utilize the ELITATM Platform. The ELITATM Platform offers surgeons an exceptionally smooth and uncomplicated lenticular removal procedure with next-day outcomes and recovery owing to its fast laser delivery technology and ultra-precise laser pulse. These advanced technologies have traditionally been expensive and inaccessible to many patients. Still, as they become more widely available, they present an opportunity for the myopia treatment market to expand its reach and provide better treatment options to a larger patient population. In addition to these advanced technologies, other emerging treatments such as orthokeratology (ortho-k) and atropine eye drops are also gaining popularity as effective methods for managing myopia. In May 2021, CooperVision Specialty EyeCare's Procornea DreamLite night lenses received European approval for slowing myopia progression in children and young adults. The popular orthokeratology contact lens is the latest CooperVision myopia control product to gain the CE Mark, joining EyeDream and Paragon CRT ortho-k designs, MiSight day soft contact lenses, and SightGlass Vision Diffusion Optics Technology spectacle lenses. These non-invasive treatments can be more affordable than surgical options, making them accessible to a wider range of patients. Overall, the rising availability of advanced technologies for treating targeted myopia presents a significant opportunity for the myopia treatment market. By providing patients with more effective and accessible treatment options, the market can help to improve vision health outcomes and address a significant unmet need in the global healthcare landscape.

Factor Hampering Myopia Treatment Market

The myopia treatment market faces a critical challenge due to the shortage of skilled eye care professionals specializing in myopia management. With the myopia epidemic affecting millions globally, the demand for proficient optometrists and ophthalmologists trained in myopia control and management has surged. However, the shortage of specialized professionals capable of effectively implementing and monitoring myopia treatment plans, such as orthokeratology and atropine therapy, has hindered the widespread adoption of these progressive treatment methods. This shortage is exacerbated by the increasing prevalence of myopia, especially in younger populations, necessitating a proactive and comprehensive approach to myopia management. Efforts to address this shortfall entail extended education and training programs that equip eyecare professionals with the necessary skills to deliver myopia-focused care. This ensures that the market can effectively meet the escalating demand for myopia treatment and contribute to improved visual health outcomes.

Myopia Treatment Market: Segmental Overview

The myopia treatment market, based on type, is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest share in the myopia treatment market in 2022. High myopia, also known as pathological or degenerative myopia, represents an advanced form of nearsightedness characterized by a significantly elongated eyeball and an increased risk of ocular complications. Individuals with high myopia often experience severe visual impairment and are susceptible to a range of sight-threatening conditions, including retinal detachment, myopic maculopathy, glaucoma, and choroidal neovascularization. This condition typically progresses during childhood and adolescence and can significantly impact an individual's quality of life, making reading and driving more challenging.

The myopia treatment market, based on treatment, is segmented into low-dose atropine eye drops, refractive surgery, contact lenses, and ortho-k. The low-dose atropine eye drops segment held the largest share of the myopia treatment market 2022. Low-dose atropine eye drops are a promising treatment for myopia, particularly in children and adolescents. Myopia, often known as nearsightedness, is a frequent refractive defect that results in fuzzy images of distant objects. Atropine is a medicine that can help slow down the progression of myopia by lowering the focusing muscles in the eye and dilating the pupil.

Myopia treatment market is segmented by age group into adult and childhood myopia. The adult myopia segment held the largest share of the myopia treatment market in 2022. Adult myopia, characterized by difficulty seeing objects at a distance, often requires corrective lenses for clear vision. The onset and progression of myopia in adulthood can impact various characteristics of daily life, from reading and computer work to driving and participating in outdoor activities. Beyond the inconvenience of relying on corrective measures, adult myopia can lead to long-term ocular health concerns, including an increased risk of developing myopic maculopathy, cataracts, and glaucoma.

On the basis of end users, Myopia treatment market is classified into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest share of the myopia treatment market in 2022. Hospitals and clinics are the primary healthcare facilities that offer treatments for various diseases and health conditions. The hospitals provide primary care with the best facilities and patient services. Multi-specialty hospitals and clinics offer several types of treatments for various eye conditions; an ophthalmologist in hospitals treats thousands of patients with various eye conditions. The treatments are easily performed in hospitals because the best doctors and assisting staff are available.

Myopia Treatment Market: Geographical Overview

The myopia treatment market, based on region, is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest share of the global myopia treatment market. Asia Pacific is estimated to register the highest CAGR from 2022 to 2030.

The US myopia treatment market is expected to experience significant growth in the coming years. The prevalence of myopia has been increasing in recent years, which is driving the demand for effective treatments. The US has reported a prevalence of 42%, nearly doubling in just three decades, according to data released by the Myopia Institute in 2023. Furthermore, increasing awareness about myopia is also driving market growth. For instance, the Brien Holden Vision Institute's 2024 Myopia Awareness Week has selected Review of Myopia Management as its official co-sponsor. The collaboration will assist in expanding the reach of Myopia Awareness Week, which is scheduled for domestically and internationally, May 13–19, 2024. More people are becoming aware of the risks associated with myopia, such as an increased risk of developing other eye conditions—cataracts and glaucoma. This has led to a greater demand for effective treatments that can help prevent or slow down the progression of myopia. Another factor driving the growth of the myopia treatment market in the US is the availability of advanced technologies and treatments. Various treatments for myopia are now available, including corrective lenses, orthokeratology, and pharmacological treatments. These treatments are becoming increasingly sophisticated and effective, helping drive demand for myopia treatment. Finally, the growing prevalence of myopia among children is also driving the growth of the myopia treatment market in the US. As more children are diagnosed with myopia, there is a greater need for effective treatments that can help prevent or slow down its progression. This has led to increased investment in research and development of new treatments specifically designed for children. Overall, the US myopia treatment market is expected to grow in the coming years as more people become aware of the condition and demand for effective treatments increases.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医薬）の最新刊レポート

The Insight Partners社の製薬分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医薬）の最新刊レポート

The Insight Partners社の製薬分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?